
ALVO vs VIR
$ALVO vs $VIR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ALVO vs VIR: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·VIR is the weaker of the two on trend, below both its 50- and 200-day averages, while ALVO has held above one of them.
- ·Only VIR beat the market over the past year, by 55.7%, while ALVO trailed the S&P 500 at +10.6% by 21.6%.
- ·The last month has flipped the order: ALVO has held up better over the month (-11.1% against -14.8%) even though VIR leads over the year.
- ·ALVO sits closer to its support, 23.3% above it at $3.49, while VIR is 33.6% above its own at $6.24.
- ·ALVO is within 1.1% of resistance at $4.60, a price where it has stalled before.
- ·VIR is within 2% of resistance at $9.58, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ALVO vs VIR: the quick read
- ·VIR is the larger company by market cap ($1.58B vs $1.56B).
- ·VIR has been more active on our scanner (161 vs 90 alerts in 30 days).
- ·VIR has the smaller float (154.7M vs 247.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 161 and 90 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·VIR pays a dividend and ALVO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching ALVO or VIR? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ALVO and VIR on TheDesperateTrader.
- Is ALVO or VIR the better stock?
- "Better" depends on your goal, and these two are not alike. VIR is the larger company by market cap ($1.58B vs $1.56B). VIR has been more active on our scanner (161 vs 90 alerts in 30 days). VIR has the smaller float (154.7M vs 247.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ALVO and VIR?
- The differences that matter: they are not in the same business - ALVO is biological products, (no diagnostic substances) and VIR is biological products, (no diagnostic substances); they are similar in size ($1.56B vs $1.58B); they trade at very different share prices ($4.55 vs $9.39); ALVO sits at 45% of its 52-week range against 45% for VIR; only VIR pays a dividend; our scanner flagged ALVO 90 times in the last 30 days against 161 for VIR. Everything above is measured from the latest completed session and SEC filings.
- Which of ALVO and VIR is more active right now?
- Right now ALVO is at about 1.4x its normal volume and VIR is at about 1.3x, so ALVO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ALVO or VIR in the stronger trend?
- ALVO is below its 50-day average of $5.18 and above its 200-day average of $4.17; VIR is below its 50-day average of $11.04 and below its 200-day average of $9.79. ALVO leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ALVO or VIR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ALVO and VIR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.